Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
about
Q24194574The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysisInduction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionA large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005.Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in GermanyThe role of older children and adults in wild poliovirus transmissionCharacterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit.Towards global poliomyelitis eradication: the successes and challenges for a developed country.Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan.Polio eradication, cessation of vaccination and re-emergence of disease.The final stages of the global eradication of poliomyelitis.Oral and inactivated poliovirus vaccines in the newborn: a review.Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.Providing monovalent oral polio vaccine type 1 to newborns: findings from a pilot birth-dose project in Moradabad district, India.Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary.Consensus recommendations on immunization and IAP immunization timetable 2012.Preeradication vaccine policy options for poliovirus infection and disease control.Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).Polio vaccination: past, present and future.Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, Western Uttar Pradesh.Phase 3 Trial of a Sabin Strain-Based Inactivated Poliovirus Vaccine.The costs of future polio risk management policies.Retrospective cost-effectiveness analyses for polio vaccination in the United States.Detection of multiple cocirculating wild poliovirus type 1 lineages through environmental surveillance: impact and progress during 2011-2013 in Pakistan.Evaluation of response scenarios to potential polio outbreaks using mathematical models.Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.Challenges faced by the global polio eradication initiativeWaning Intestinal Immunity After Vaccination With Oral Poliovirus Vaccines in India
P2860
Q24194574-491847AD-59AE-479B-9E37-21A1276F38CDQ24617876-6838F988-C9EB-48BA-99DB-25FD2D4680D8Q27001897-B3B51C6E-5EAB-43E2-B00B-C75AA4B5F99EQ30840117-5A0E7774-5017-4B5E-83D8-77F91DC7127AQ33766951-728E6598-55E6-4096-B19D-7C20788CB8EAQ33971682-EA97CB55-68EE-4E9C-AF3E-0AF7E78D4BA8Q34632088-E43FABF2-CEA6-41CE-935D-94B3C0703CA0Q34933032-619C2F0D-E530-46E3-B738-AB3A9C2F7317Q35589486-606A0486-E316-4A79-81F5-1DAA65A09F9BQ35661264-F0BC6D32-D680-4F57-9F0C-39B7A7B79FA2Q35777670-D013EE56-F847-4B3E-A043-567C4702769BQ37037388-80976809-138F-4358-B6D8-E58270D936E3Q37164542-54F2CC13-EB61-4224-862E-F07DB7BEBF7FQ37333852-37809936-1D22-4F95-A5C8-42EA05D9F620Q37461749-05233F9A-9643-42B9-B4A6-C4052D6A676AQ37891602-5B76DDCB-5289-43A5-9377-9D46883D036DQ38033977-FCC8B62D-5E75-47B0-A78D-60182FE1A598Q38086593-6D32AE13-D619-4B9E-8F30-22AC758C94D0Q38087428-33ED0126-5A02-41A0-806B-492F4F93D945Q38396773-3442932D-3F47-4D1D-AABE-0459DA726B3DQ39112956-71BB3F6D-207B-46C1-9062-869575EBD06AQ40087779-4323A89E-6818-45B9-BAD0-2FEE4C0CFB35Q40258086-28455A52-C89C-4BD0-BAB2-A92858B8AF29Q40258094-F848BA2E-EDF4-4F0F-BE61-BA5228999D6BQ42183592-0F016892-4D02-4B35-964A-D52C6036130AQ44136457-8E00AC46-C97D-477E-9E71-9A49E53D011CQ50183859-5B039DB1-E63F-45A1-87E7-95806B9D200BQ56699815-CABB4EB0-397E-477F-AC8F-8E224D875357Q57210071-055D6F15-1AD6-42F5-A7F5-A398F2AB3520
P2860
Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Sabin monovalent oral polio va ...... l use after polio eradication.
@ast
Sabin monovalent oral polio va ...... l use after polio eradication.
@en
type
label
Sabin monovalent oral polio va ...... l use after polio eradication.
@ast
Sabin monovalent oral polio va ...... l use after polio eradication.
@en
prefLabel
Sabin monovalent oral polio va ...... l use after polio eradication.
@ast
Sabin monovalent oral polio va ...... l use after polio eradication.
@en
P2860
P356
P1476
Sabin monovalent oral polio va ...... l use after polio eradication.
@en
P2093
P2860
P304
P356
10.1086/321905
P407
P577
2001-07-09T00:00:00Z